-

Deadline Alert: Integral Ad Science Holding Corp. (IAS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming March 31, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

IF YOU SUFFERED A LOSS ON YOUR IAS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?

On August 3, 2023, after market hours, IAS released its second quarter 2023 financial results, revealing that the growth of its optimization revenue had slowed, citing “maturing Context Control growth” and “slower demand from tech/telco clients.” On this news, IAS’s stock price fell $3.66, or 19.4%, to close at $15.17 per share on August 4, 2023, thereby injuring investors.

Then, on February 27, 2024, after market hours, IAS released its fourth quarter 2023 financial results, missing consensus estimates due to pricing cuts issued to customers across the Company’s measurement and optimization businesses and “more competitive pricing.”

On this news, IAS’s stock price fell $7.09, or 41.5%, to close at $10.01 per share on February 28, 2024, thereby injuring investors further.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that IAS was experiencing a new material trend of increased competitive pricing pressures and that, as a result, IAS had been forced to cut prices to compensate for weakening demand and slowing revenue growth; (2) that IAS’s pricing function was no longer “favorable” and IAS could not sustain its pricing and drive price increases; (3) that pricing had become a key differentiator between IAS and its competitor necessary to close major renewals and new deals; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired IAS common stock during the Class Period, you may move the Court no later than March 31, 2025 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Charles Linehan, Esq.,
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Contact Us:
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Glancy Prongay & Murray LLP

NASDAQ:IAS

Release Versions

Contacts

Contact Us:
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

More News From Glancy Prongay & Murray LLP

Glancy Prongay Wolke & Rotter Scores Top Securities Settlement of 2025

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (GPWR) is proud to announce that the Firm, as sole lead counsel for Alibaba investors, attained the highest securities class action settlement of 2025, according to prominent national economic consulting firm, NERA. Spearheaded by partners Kara Wolke and Melissa Wright, GPWR leveraged its deep experience and tenacious advocacy into a $433.5 million settlement for the benefit of Alibaba’s investors. Injured by fraud or corporate...

PSFE CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Paysafe Limited Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Singh v. Paysafe Limited, et al., Case No. 1:26-cv-01048, on behalf of persons and entities that purchased or otherwise acquired Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”). Plaintiff...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Oracle Corporation (ORCL) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Oracle Corporation (“Oracle” or the “Company”) (NYSE: ORCL) securities between June 12, 2025 and December 16, 2025, inclusive (the “Class Period”). Oracle investors have until April 6, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR...
Back to Newsroom